Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Determine the Safety, Efficacy, and Pharmacokinetics of 80,160 and 320mg ALD518 Versus Placebo Administered as Multiple IV Infusions to Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate

NCT00867516 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT00867516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00867516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Determine the Safety, Efficacy, and Pharmacokinetics of 80,160 and 320mg ALD518 Versus Placebo Administered as Multiple IV Infusions to Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Lead sponsor
CSL Behring
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2008
Completion date
December 31, 2009
Enrollment
127 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid